HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 20 July 2011

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 29 papers were listed this time. Here's a handful in our areas of our research interest:

Campbell HE, Epstein D, et al. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. Eur  J Cancer. 2011 Jul 7. [Epub ahead of print] PubMed PMID: 21741831.

Sullivan SD, Garrison LP, Rinde H, Kolberg J, Moler EJ. Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score. J Med Econ. 2011 Jul 11. [Epub ahead of print] PubMed PMID: 21740291.

Kobelt G, Lekander I, Lang A, et al. Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment. Int J Technol Assess Health Care. 2011 Jul 8:1-8. [Epub ahead of print] PubMed PMID: 21736857.

Lazar LD, Pletcher MJ, Coxson PG, et al. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011 Jul 12;124(2):146-53. Epub 2011 Jun 27. PubMed PMID: 21709063.

Mueller D, Gandjour A. Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis. Appl Health Econ Health Policy. 2011 Jul 1;9(4):259-73. PubMed PMID: 21682353.